ATTENUATION OF EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS BY COMPOUND 48-80 IN LEWIS RATS

被引:25
|
作者
STANLEY, NC [1 ]
JACKSON, FL [1 ]
ORR, EL [1 ]
机构
[1] TEXAS COLL OSTEOPATH MED,DEPT ANAT & CELL BIOL,3500 CAMP BOWIE BLVD,FT WORTH,TX 76107
关键词
Compound; 48/80; Experimental autoimmune encephalomyelitis; Lewis rat; Mast cell;
D O I
10.1016/0165-5728(90)90165-J
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The appearance of increased levels of histamine in the central nervous system (CNS) concomitant with the development of clinically significant acute experimental autoimmune encephalomyelitis (EAE) in male Lewis rats suggests that CNS-associated mast cells may mediate acute EAE in Lewis rats. We now report that, compared to controls, rats with acute EAE exhibit fewer detectable mast cells in their dura mater and velum interpositum. In addition, intracisternal, but not intraperitoneal administration of Compound 48/80 just prior to the appearance of clinical signs of acute or recurrent EAE in male and female rats, respectively, significantly attenuates the clinical severity of both forms of EAE. These results further support the hypothesis that CNS-associated, but not peripheral mast cells are mediators or modulators of acute and recurrent EAE in Lewis rats. © 1990.
引用
收藏
页码:223 / 228
页数:6
相关论文
共 50 条
  • [31] RELEASE OF ADENOSINE FROM RAT LUNG BY ANTIGEN AND COMPOUND 48-80
    FREDHOLM, BB
    ACTA PHYSIOLOGICA SCANDINAVICA, 1981, 111 (04): : 507 - 508
  • [32] Vitamin K2 ameliorates experimental autoimmune encephalomyelitis in Lewis rats
    Moriya, M
    Nakatsuji, Y
    Okuno, T
    Sakoda, S
    MULTIPLE SCLEROSIS, 2005, 11 : S49 - S49
  • [33] Gangliosides do not elicit experimental autoimmune encephalomyelitis in Lewis rats and SJL mice
    Sáez-Torres, I
    Díaz-Villoslada, P
    Martínez-Cáceres, E
    Ferrer, I
    Montalban, X
    JOURNAL OF NEUROIMMUNOLOGY, 1998, 84 (01) : 24 - 29
  • [34] Preventive but not therapeutic application of Rolipram ameliorates experimental autoimmune encephalomyelitis in Lewis rats
    Jung, S
    Zielasek, J
    Kollner, G
    Donhauser, T
    Toyka, K
    Hartung, HP
    JOURNAL OF NEUROIMMUNOLOGY, 1996, 68 (1-2) : 1 - 11
  • [35] Mechanism of experimental autoimmune encephalomyelitis in Lewis rats: recent insights from macrophages
    Shin, Taekyun
    Ahn, Meejung
    Matsumoto, Yoh
    ANATOMY & CELL BIOLOGY, 2012, 45 (03) : 141 - 148
  • [36] Amelioration of experimental autoimmune encephalomyelitis in lewis rats by FTY720 treatment
    Fujino, M
    Funeshima, N
    Kitazawa, Y
    Kimura, H
    Amemiya, H
    Suzuki, S
    Li, XK
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 305 (01): : 70 - 77
  • [37] Vitamin K2 ameliorates experimental autoimmune encephalomyelitis in Lewis rats
    Moriya, M
    Nakatsuji, Y
    Okuno, T
    Hamasaki, T
    Sawada, M
    Sakoda, S
    JOURNAL OF NEUROIMMUNOLOGY, 2005, 170 (1-2) : 11 - 20
  • [38] Peptide T does not ameliorate experimental autoimmune encephalomyelitis (EAE) in Lewis rats
    Sáez-Torres, I
    Espejo, C
    Pérez, JJ
    Acarín, N
    Montalban, X
    Martínez-Cáceres, EM
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2000, 121 (01): : 151 - 156
  • [39] Vitamin K2 ameliorates experimental autoimmune encephalomyelitis in lewis rats
    Moriya, M.
    Nakatsuji, Y.
    Okuno, T.
    Sakoda, S.
    JOURNAL OF NEUROIMMUNOLOGY, 2006, 178 : 167 - 167
  • [40] Suppression of cell-transferred experimental autoimmune encephalomyelitis in defibrinated Lewis rats
    Inoue, A
    Koh, CS
    Shimada, K
    Yanagisawa, N
    Yoshimura, K
    JOURNAL OF NEUROIMMUNOLOGY, 1996, 71 (1-2) : 131 - 137